• Epi Biotech set an extraordinary shareholder meeting for Nov. 25, 2026.
• Votes will be held on appointing Hwang Man-soon as a new non-executive director for a three-year term.
• Shareholders will also decide on naming Noh Min-su as a new independent director for a three-year term.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Epi Biotech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014600270), on October 14, 2026, and is solely responsible for the information contained therein.